Importance of Selecting the Appropriate Therapy for Inflammatory Bowel Disease in the Managed Care Environment

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye

Proofreaders

Griselda DemasseyMaggie Shaw

Associate Editor

Jeanne Linke

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle ConsolaMichael Costella

Corporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

President

Mike Hennessy, Jr

Chief Operating Officer and Chief Financial Officer

Neil Glasser, CPA/CFE

President, Managed Markets, Pharmacy, and Rare Disease

Brian Haug

Executive Vice President and General Manager

John Maglione

Chief Creative Officer

Jeff Brown

Human Resources Director

Shari Lundenberg

Facutly

Sheila M. Wilhlem, PharmD, FCCP, BCPS

Clinical Associate Professor

Department of Pharmacy Practice

Wayne State University

Detroit, Michigan

Clinical Pharmacy Specialist

Internal Medicine

Harper University Hospital

Detroit, Michigan

Bryan L. Love, PharmD, BCPS

Clinical Associate Professor

Clinical Pharmacy and Outcomes Sciences Department

South Carolina College of Pharmacy University of South Carolina

Columbia, South Carolina

Foram Mehta, MS, RPh

Pharmacy Service Manager

Aetna Medicare

Old Bridge, New Jersey

Editorial Support

Christine Sokoloski, MS

Medical Writer

Hillsborough, New Jersey

Jill E. Allen, PharmD

Drug Information Consultant

Pink Oak Associates

Salt Lake City, Utah

Priya Karkhanis

Scientific Consultant

Hillsborough, New Jersey

Participating Faculty

Faculty Disclosures

Sheila M. Wilhelm, PharmD, FCCP, BCPS; Bryan L. Love, PharmD, BCPS;

Foram Mehta, MS, RPh;

and have no relevant financial relationships with commercial interests to disclose.

Editorial Support

Christine Sokoloski, MS; Jill E. Allen, PharmD;

and Priya Karkhanis; have no relevant financial relation-ships with commercial interests to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel; have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education

Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Donna Fausak; Nathalie Harden; and Tara DeLorenzo; have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any rel-evant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be incon-sistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist rela-tive to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.

Download PDF: Importance of Selecting the Appropriate Therapy for Inflammatory Bowel Disease in the Managed Care Environment